DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Mar 25, 2022 · 4y ago · Accession 0001104659-22-037696
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Mar 25, 2022
- Report date
- Apr 26, 2022
- Document
- tm223406-1_def14a.htm
- Size
- 2.6 MB